131 related articles for article (PubMed ID: 19748086)
1. Discontinuation of hormone therapy in the French GAZEL cohort 1990-2006.
Ringa V; Fritel X; Varnoux N; Zins M; Quelen C; Bouyer J
Fertil Steril; 2010 Sep; 94(4):1387-1391. PubMed ID: 19748086
[TBL] [Abstract][Full Text] [Related]
2. Hormone therapy use among postmenopausal French women before the publication of the Women's Health Initiative study: duration of use and factors associated with discontinuation.
Ringa V; Varnoux N; Piault S; Bréart G
Fertil Steril; 2005 Jun; 83(6):1771-9. PubMed ID: 15950650
[TBL] [Abstract][Full Text] [Related]
3. Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women's Health Initiative?
Fournier A; Fritel X; Panjo H; Zins M; Ringa V
Menopause; 2014 Jul; 21(7):687-93. PubMed ID: 24378763
[TBL] [Abstract][Full Text] [Related]
4. Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results.
Crawford SL; Crandall CJ; Derby CA; El Khoudary SR; Waetjen LE; Fischer M; Joffe H
Menopause; 2018 Dec; 26(6):588-597. PubMed ID: 30586004
[TBL] [Abstract][Full Text] [Related]
5. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
[TBL] [Abstract][Full Text] [Related]
6. Personality and hormone therapy use among postmenopausal women in the GAZEL cohort study.
Lemogne C; Consoli SM; Panjo H; Nabi H; Goldberg M; Zins M; Ringa V
Fertil Steril; 2012 Oct; 98(4):929-36. PubMed ID: 22763102
[TBL] [Abstract][Full Text] [Related]
7. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
8. How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes.
Bush TM; Bonomi AE; Nekhlyudov L; Ludman EJ; Reed SD; Connelly MT; Grothaus LC; LaCroix AZ; Newton KM
J Gen Intern Med; 2007 Sep; 22(9):1311-6. PubMed ID: 17634782
[TBL] [Abstract][Full Text] [Related]
9. The 2017 Women's Health Initiative study and use of hormone therapy: an emulated repeated cross-sectional study.
Chueh CH; Ho PK; Li WH; Shiu MN; Wang IT; Wen YW; Tsai YW
BMC Public Health; 2024 Jun; 24(1):1674. PubMed ID: 38914983
[TBL] [Abstract][Full Text] [Related]
10. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
Barber CA; Margolis K; Luepker RV; Arnett DK
J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
[TBL] [Abstract][Full Text] [Related]
11. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
Schonberg MA; Wee CC
J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005
[TBL] [Abstract][Full Text] [Related]
12. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
[TBL] [Abstract][Full Text] [Related]
13. Hormones down under: hormone therapy use after the Women's Health Initiative.
Travers C; O'Neill SM; Khoo SK; King R
Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):330-5. PubMed ID: 16866795
[TBL] [Abstract][Full Text] [Related]
14. Use and perception of hormone therapy following media reports of the Women's Health Initiative: a survey of Australian WISDOM participants.
Paine BJ; Stocks NP; Ramsay EN; Ryan P; MacLennan AH;
Climacteric; 2004 Jun; 7(2):143-52. PubMed ID: 15497903
[TBL] [Abstract][Full Text] [Related]
15. Women's use of hormone therapy before and after the Women's Health Initiative: a psychosocial model of stability and change.
Gerend MA; Aiken LS; Erchull MJ; Lapin A
Prev Med; 2006 Sep; 43(3):158-64. PubMed ID: 16750263
[TBL] [Abstract][Full Text] [Related]
16. The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: A cohort study.
Tuomikoski P; Lyytinen H; Korhonen P; Hoti F; Vattulainen P; Gissler M; Ylikorkala O; Mikkola TS
Maturitas; 2015 Jul; 81(3):384-8. PubMed ID: 25912424
[TBL] [Abstract][Full Text] [Related]
17. Attitudes of women who are currently using or recently stopped estrogen replacement therapy with or without progestins: results of the AWARE survey.
Sawka AM; Huh A; Dolovich L; Papaioannou A; Eva K; Thabane L; Gafni A; Cullimore A; Macdougall M; Steiner M; Adachi JD
J Obstet Gynaecol Can; 2004 Nov; 26(11):967-73. PubMed ID: 15560859
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents.
Heinemann K; Rübig A; Strothmann A; Nahum GG; Heinemann LA
J Womens Health (Larchmt); 2008 Sep; 17(7):1151-66. PubMed ID: 18774896
[TBL] [Abstract][Full Text] [Related]
19. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
20. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
